Triamcinolone and Gemzar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triamcinolone (triamcinolone) and Gemzar (gemcitabine hydrochloride). Common drug interactions include blood potassium decreased among females and oedema peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Triamcinolone and Gemzar. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.

What is Gemzar?

Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.

On Aug, 12, 2026

22 people who take Triamcinolone and Gemzar together, and have interactions are studied.

Triamcinolone and Gemzar drug interactions.

What are the common drug interactions of Triamcinolone and Gemzar, by gender? *:

female:

Blood potassium decreased
International normalised ratio increased
Haemorrhagic anaemia (anaemia due to excessive bleeding)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)

male:

Oedema peripheral (superficial swelling)
Dyspnoea (difficult or laboured respiration)
Blood creatinine increased
Bone disorder
Breath odour
Breath sounds
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac arrest
Cataract (clouding of the lens inside the eye)
Cerebral atrophy (decrement in size of brain)

What are the common drug interactions of Triamcinolone and Gemzar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Actinic keratosis (skin disease due to sun exposure)
Erythema (redness of the skin)
Oedema peripheral (superficial swelling)
Peripheral t-cell lymphoma unspecified (peripheral t-cell cancer unspecified)
Pyoderma (any skin disease that is pyogenic)
General physical health deterioration (weak health status)
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)
Sunburn
Acute respiratory failure
Asthenia (weakness)

50-59:

Sinus disorder (disease of sinus)
Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Nasal septum deviation (deviated nasal septum)
Nasal septum perforation (hole in nasal septum)
Staphylococcal infection (an infection with staphylococcus bacteria)
Streptococcus test positive
Anisocytosis (patient's red blood cells are of unequal size)
Anticonvulsant drug level below therapeutic

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Abdominal pain lower
Constipation
Deafness
Death
Decreased appetite
Disease progression
Fatigue (feeling of tiredness)
Haemorrhagic anaemia (anaemia due to excessive bleeding)
Headache (pain in head)

What are the existing conditions these people have? *

Pain: 8 people, 36.36%
Metastases To Bone (cancer spreads to bone): 8 people, 36.36%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 7 people, 31.82%
Tumor: 4 people, 18.18%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 18.18%
Type 2 Diabetes: 2 people, 9.09%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 9.09%
High Blood Pressure: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone and Gemzar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously